View in EDS

Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.

Saved in:
Bibliographic Details
Title: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Authors: Rascol, Olivier1 (AUTHOR), Tönges, Lars1,2,3 (AUTHOR) lars.toenges@ruhr-uni-bochum.de, deVries, Tina4 (AUTHOR), Jaros, Mark4,5 (AUTHOR), Quartel, Adrian6 (AUTHOR), Jacobs, David4 (AUTHOR), ALLAY-LID I and ALLAY-LID II study groups (CORPORATE AUTHOR)
Source: Parkinsonism & Related Disorders. Mar2022, Vol. 96, p65-73. 9p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 156844907
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Rascol%2C+Olivier%22">Rascol, Olivier</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tönges%2C+Lars%22">Tönges, Lars</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> lars.toenges@ruhr-uni-bochum.de</i><br /><searchLink fieldCode="AR" term="%22deVries%2C+Tina%22">deVries, Tina</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jaros%2C+Mark%22">Jaros, Mark</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Quartel%2C+Adrian%22">Quartel, Adrian</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jacobs%2C+David%22">Jacobs, David</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22ALLAY-LID+I+and+ALLAY-LID+II+study+groups%22">ALLAY-LID I and ALLAY-LID II study groups</searchLink> (CORPORATE AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Parkinsonism+%26+Related+Disorders%22">Parkinsonism & Related Disorders</searchLink>. Mar2022, Vol. 96, p65-73. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=156844907
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.parkreldis.2022.01.022
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 65
    Titles:
      – TitleFull: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rascol, Olivier
      – PersonEntity:
          Name:
            NameFull: Tönges, Lars
      – PersonEntity:
          Name:
            NameFull: deVries, Tina
      – PersonEntity:
          Name:
            NameFull: Jaros, Mark
      – PersonEntity:
          Name:
            NameFull: Quartel, Adrian
      – PersonEntity:
          Name:
            NameFull: Jacobs, David
      – PersonEntity:
          Name:
            NameFull: ALLAY-LID I and ALLAY-LID II study groups
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 13538020
          Numbering:
            – Type: volume
              Value: 96
          Titles:
            – TitleFull: Parkinsonism & Related Disorders
              Type: main
ResultId 1